South Dakota Investment Council’s Ligand Pharmaceuticals LGND Stock Holding History

South Dakota Investment Council’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,057	Closed	-$766K	–	604
2021 Q1	$766K	Buy	8,057 +71	+0.9%	+$6.71K	0.01%	507
2020 Q4	$495K	Hold	7,986	–	–	0.01%	520
2020 Q3	$475K	Hold	7,986	–	–	0.01%	503
2020 Q2	$557K	Hold	7,986	–	–	0.01%	475
2020 Q1	$362K	Hold	7,986	–	–	0.01%	480
2019 Q4	$520K	Sell	7,986 -831	-9%	-$55.5K	0.01%	490
2019 Q3	$547K	Hold	8,817	–	–	0.01%	516
2019 Q2	$628K	Hold	8,817	–	–	0.01%	485
2019 Q1	$691K	Buy	8,817 +1,764	+25%	+$134K	0.01%	469
2018 Q4	$597K	Buy	7,053 +2,725	+63%	+$291K	0.02%	451
2018 Q3	$741K	Buy	+4,328	New	+$652K	0.02%	456

Other funds holding LGND

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

South Dakota Investment Council's LGND Position: Q2 2021 in Review

South Dakota Investment Council sold out of Ligand Pharmaceuticals (LGND) in Q2 2021, closing a stake of 8,057 shares — an estimated $766K sold.

South Dakota Investment Council first reported a position in LGND in Q3 2018 and held it in 11 quarters. The position peaked at $766K in Q1 2021. 212 funds tracked by Wall St. Rank hold LGND as of Q2 2021.

South Dakota Investment Council reported no remaining Ligand Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
South Dakota Investment Council sold 8,057 Ligand Pharmaceuticals shares in Q2 2021, an estimated $766K.
South Dakota Investment Council first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 11 quarters.
South Dakota Investment Council's Ligand Pharmaceuticals position peaked at $766K in Q1 2021.
212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2021.

Based on South Dakota Investment Council's 13F filing for Q2 2021, filed 11 Aug 2021.